{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:53:37Z","timestamp":1781783617434,"version":"3.54.5"},"reference-count":13,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,6,13]]},"DOI":"10.1080\/14656566.2026.2677642","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:01:43Z","timestamp":1779181303000},"page":"729-732","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["What is the emerging role of RNA interference in HBV cure strategies?"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3534-6349","authenticated-orcid":false,"given":"Zillah","family":"Cargill","sequence":"first","affiliation":[{"name":"Kings College Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Kings College Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"e_1_3_3_3_1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Org; 2024."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00197-8"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409028102"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.31"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-020-00548-4"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/418244a"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00148-6"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405485"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04049-z"},{"key":"e_1_3_3_12_1","article-title":"IM-PROVE I: characterization of chronic hepatitis B (CHB) subjects with functional cure or HBV DNA suppression after completion of imdusiran plus short courses of pegylated interferon alfa-2a (IFN) and discontinuation of nucleos (t) ide analogue (NA) therapy","author":"Yuen M-F","year":"2025","unstructured":"Yuen M-F, Nahass RG, Wong GL-H, et al. IM-PROVE I: characterization of chronic hepatitis B (CHB) subjects with functional cure or HBV DNA suppression after completion of imdusiran plus short courses of pegylated interferon alfa-2a (IFN) and discontinuation of nucleos (t) ide analogue (NA) therapy. J Hepatol. 2025;82(2025):S836-S836.","journal-title":"J Hepatol"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00694-x"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11090778"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.02.016"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2677642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:27:21Z","timestamp":1781782041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2677642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6,13]]}},"alternative-id":["10.1080\/14656566.2026.2677642"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2677642","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}